I ran into a nice burly fellow on the street Saturday night, and because he was wearing a COLT wife-beater I said hello and invited him upstairs for stranger sex. I was drunk and had run out of polyurethane condoms so I stuck it in raw. It seemed like a great decision until I came. Now I’m on post-exposure prophylaxis for the second time.
Last time I went on PEP they gave me Combivir, but now I’m lucky enough to be on Truvada, which has fewer side effects and unlike Combivir goes fine with alcohol. It all seems so apropos of Steve Handley’s Issue 3 piece on Truvada. The whole thing is even more timely given the news last month that the FDA is approving trial runs for the use of Truvada as PrEP, pre-exposure prophylaxis.
The idea is that some men would rather take a pill a day than use condoms. That’s all well and good for as long as the makers of Truvada are fronting the bill in return for research, but I’m not sure how feasible the condom pass will be once the $1,000-per-month pills need to get paid for.